Skylark Bio has dosed the first patient in a Phase [...]
CAMP4 Therapeutics has received Australian regulatory and ethics clearance to [...]
Skylark Bio has dosed the first patient in a Phase [...]
CAMP4 Therapeutics has received Australian regulatory and ethics clearance to [...]